Siemens Mobility To Divest Yunex Traffic To Atlantia For EUR 950 Mln

Siemens Mobility said it signed an agreement to divest Yunex Traffic, the international road traffic business, to Atlantia S.p.A for enterprise value of 950 million euros.

The agreement marks the conclusion of a bidding process launched by Siemens in recent months, and which has seen Atlantia beat off competition from a large number of international bidders, Atlantia said in a statement.

Closing is expected by September 2022, subject to the relevant regulatory approvals.

Munich-based Yunex Traffic is a global leader in the Intelligent Transport Systems and Smart Mobility businesses. Its traffic management and urban mobility infrastructure and platforms are used in over 600 cities and on four continents (Europe, the Americas, Asia and Oceania).

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT